Article Details
Retrieved on: 2022-12-24 17:07:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) ...
Article found on: www.bakersfield.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here